Pioneering Doctor Dies After Experimental Brain Cancer Treatment

Pioneering Australian doctor Richard Scolyer has passed away at the age of 59, three years after being diagnosed with an aggressive glioblastoma. Dr. Scolyer gained international attention for participating in a groundbreaking experimental treatment for his brain tumor, a therapy derived from his and Professor Georgina Long's significant scientific advancements in skin cancer.

Their research on advanced melanoma, once considered a near-certain death sentence, has dramatically improved survival rates, with nearly half of patients now essentially cured, a stark contrast to previous outcomes of less than 10%. The encouraging results from Scolyer's own experimental treatment have now led to an early-stage clinical trial in the United States.

Dr. Scolyer, a highly respected medical mind and co-director of Melanoma Institute Australia, was named Australian of the Year in 2024 alongside Professor Long. He expressed a desire to continue contributing even in his final days, stating his hope to change the future for others and leave the world a better place through his work and mentorship of aspiring pathologists.

He described his shock diagnosis and subsequent decision to undergo the experimental treatment as a refusal to "accept certain death without trying something." The treatment involved combination, pre-surgery immunotherapy and a personalized vaccine, marking him as the first brain cancer patient to receive such a protocol. While the odds of a cure were considered minuscule, the treatment showed a positive immune response, inspiring the ongoing clinical trial. Dr. Scolyer is survived by his wife and three children.